These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 21857253)

  • 1. Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest.
    Zeliadt SB; Sekaran NK; Hu EY; Slatore CC; Au DH; Backhus L; Wu DY; Crawford J; Lyman GH; Dale DC
    J Thorac Oncol; 2011 Oct; 6(10):1726-32. PubMed ID: 21857253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
    Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical resection and long-term survival for octogenarians who undergo surgery for non-small-cell lung cancer.
    Dillman RO; Zusman DR; McClure SE
    Clin Lung Cancer; 2009 Mar; 10(2):130-4. PubMed ID: 19362957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study.
    Sakurai H; Asamura H; Goya T; Eguchi K; Nakanishi Y; Sawabata N; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Oct; 5(10):1594-601. PubMed ID: 20736855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcome of stage IIIA- cN2/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004.
    Yoshino I; Yoshida S; Miyaoka E; Asamura H; Nomori H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
    J Thorac Oncol; 2012 May; 7(5):850-5. PubMed ID: 22481238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.
    Osarogiagbon RU; Lin CC; Smeltzer MP; Jemal A
    J Thorac Oncol; 2016 Jan; 11(1):e5-16. PubMed ID: 26762752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients.
    Goodgame B; Viswanathan A; Zoole J; Gao F; Miller CR; Subramanian J; Meyers BF; Patterson AG; Govindan R
    J Thorac Oncol; 2009 Nov; 4(11):1370-4. PubMed ID: 19692932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.
    Osarogiagbon RU; Yu X
    J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.
    Kasprzyk M; Dyszkiewicz W; Piwkowski C; Brudlo M; Galecki B; Gabryel P; Gasiorowski L
    Neoplasma; 2013; 60(1):62-7. PubMed ID: 23067218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.
    Robinson CG; DeWees TA; El Naqa IM; Creach KM; Olsen JR; Crabtree TD; Meyers BF; Puri V; Bell JM; Parikh PJ; Bradley JD
    J Thorac Oncol; 2013 Feb; 8(2):192-201. PubMed ID: 23287852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time trends of overall survival and survival after recurrence in completely resected stage I non-small cell lung cancer.
    Hung JJ; Jeng WJ; Hsu WH; Huang BS; Wu YC
    J Thorac Oncol; 2012 Feb; 7(2):397-405. PubMed ID: 22173701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of gross tumor volume for definitive radiation therapy in patients with locoregionally recurrent non-small-cell lung cancer after surgical resection.
    Lee NK; Moon SH; Kim TH; Han JY; Yun T; Kim HT; Lee HS; Kim MS; Lee JM; Cho KH; Lee JS
    Clin Lung Cancer; 2013 Jul; 14(4):399-406. PubMed ID: 23276823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
    Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis.
    Subramanian J; Morgensztern D; Goodgame B; Baggstrom MQ; Gao F; Piccirillo J; Govindan R
    J Thorac Oncol; 2010 Jan; 5(1):23-8. PubMed ID: 19934774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes in Early-stage NSCLC Treated with Stereotactic Body Radiotherapy Versus Surgical Resection.
    Kastelijn EA; El Sharouni SY; Hofman FN; Van Putte BP; Monninkhof EM; Van Vulpen M; Schramel FM
    Anticancer Res; 2015 Oct; 35(10):5607-14. PubMed ID: 26408733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resection rate and outcome of pulmonary resections for non-small-cell lung cancer: a nationwide study from Iceland.
    Thorsteinsson H; Alexandersson A; Oskarsdottir GN; Skuladottir R; Isaksson HJ; Jonsson S; Gudbjartsson T
    J Thorac Oncol; 2012 Jul; 7(7):1164-9. PubMed ID: 22592213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
    Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
    Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term impact of surgical complications after resection of stage I nonsmall cell lung cancer: a population-based survival analysis.
    Rueth NM; Parsons HM; Habermann EB; Groth SS; Virnig BA; Tuttle TM; Andrade RS; Maddaus MA; D'Cunha J
    Ann Surg; 2011 Aug; 254(2):368-74. PubMed ID: 21617585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
    Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ
    Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.